Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-094380
Filing Date
2024-08-09
Accepted
2024-08-09 09:05:04
Documents
62
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q alvr-20240630.htm   iXBRL 10-Q 1898868
2 EX-31.1 alvr-ex31_1.htm EX-31.1 14665
3 EX-31.2 alvr-ex31_2.htm EX-31.2 15753
4 EX-32.1 alvr-ex32_1.htm EX-32.1 8390
5 EX-32.2 alvr-ex32_2.htm EX-32.2 8428
  Complete submission text file 0000950170-24-094380.txt   6450795

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alvr-20240630.xsd EX-101.SCH 870001
65 EXTRACTED XBRL INSTANCE DOCUMENT alvr-20240630_htm.xml XML 871713
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

EIN.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39409 | Film No.: 241190568
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)